Maharashtra FDA hits Patanjali Foods with notice over Karela Jamun Juice claims, recall looms
Maharashtra FDA has issued Patanjali Foods a formal notice over labelling and medicinal claims on its Karela Jamun Juice, with a mandatory recall on the table. The action targets the company's health-segment portfolio and adds fresh regulatory overhang to its packaged consumer business.
What happened
Maharashtra FDA issued a formal notice to Patanjali Foods over labelling and medicinal claims on its Karela Jamun Juice, threatening a mandatory recall of the
Key facts
- ₹650 crore
- ₹235.26 crore
- ₹315 crore
- 20 lakh homes
- 60:40 JV
Why this matters
Reassess valuation and diligence assumptions on any Patanjali-adjacent or Ayurveda-branded targets, as label-claim liability is now a live deal-risk factor in Indian FMCG health portfolios.